Phenomenex, Inc., a global leader in the separation sciences business, announced that today marks 25 years since the company's founding.
TORRANCE, Calif. (BusinessWire EON) March 20, 2007 --
Phenomenex, Inc., a global leader in the separation sciences business,
announced that today marks 25 years since the company’s
founding.
Headquartered in Torrance, Phenomenex is a technology pioneer in
developing and manufacturing chromatography products used in the
separation, analysis and purification of pharmaceuticals,
biopharmaceuticals and a broad spectrum of chemicals. With projected ’07
sales exceeding $110 million and 465 employees, privately held
Phenomenex has offices in Canada, the U.K., Germany, Austria, France,
Italy, Denmark, Australia and New Zealand.
“Our leadership position is driven by a
constant focus to innovate,” says Fasha
Mahjoor, founder and chief executive officer. “Technology
innovations set the benchmark and cover the entire spectrum of
chromatography products.
“We lead the market in products for High
Performance Liquid Chromatography (HPLC), especially advanced separation
devices used by the life sciences, environmental, chemical and
healthcare related industries.
“Our products for sample preparation are
cutting-edge, in particular the consumable products we’ve
developed for solid phase extraction, sample enrichment and sample
collection. And our Gas Chromatography products have been adopted
extensively by the environmental, petrochemical and healthcare market
sectors.”
Mahjoor is understandably proud of the distance Phenomenex has traveled
in 25 years. He attributes a number of strategic factors to its success.
“I believe well-placed investments in
research, new product development and human capital, along with
carefully nurturing a unique, service driven culture, have cast our
reputation as an innovator and helped us seize the leadership role we
have today,” Mahjoor says.
Mahjoor considers the recognition Phenomenex has earned for its
technology advancements to be an important success measure. He cites
winning one of the coveted “R&D 100”
Awards, the prestigious awards given annually by R&D Magazine
for the 100 best new product ideas, as the most recent example.
“A few months ago we were honored to see a
Phenomenex team win an ‘R&D 100 Award,’
the ‘Oscar of Invention,’
for their work in creating a novel, patented technology called Axia™,”
says Mahjoor.
“Not only is this advanced separation device
incredibly sleek and beautifully designed, but it is also an enabling
technology for rapid discovery and optimization of lead compounds. It
represents a quantum improvement in purification technology,
transforming the speed and reliability of the purification process as
well as providing significantly improved column lifetimes.”
Looking to the future, Mahjoor is excited about the challenges and
opportunities as well as the potential for growth and greater success.
He also wants to make sure that the values he has worked hard to instill
remain embedded in the Company’s DNA.
“From the outset I envisioned a company
founded on the ethic of providing an uncommon level of service to
others. That’s what makes Phenomenex a
different kind of company to work for and do business with,”
he says.
“Building a ‘service-driven
culture’ to meet the needs of our customers
has been our success formula. It has fueled our growth rate, which
historically has averaged 15 to 25 percent annually, well above those of
our peers.
“If we stay committed to our principles, keep
close to our customers and continue to read the market right, I’m
convinced that the next 25 years will be even more successful and
noteworthy than the past we celebrate today.”
Phenomenex, Inc.
Phenomenex, Inc., a global leader in separation sciences technology, is
a privately held corporation headquartered in Torrance, California.
Phenomenex is celebrating 25 years of innovation and achievement,
marking its birth as a company driven by a constant focus to innovate.
Phenomenex develops, manufactures and distributes chromatography
products for the separation, analysis and purification of
pharmaceuticals, biopharmaceuticals and a broad spectrum of chemicals.
It serves a broad base of customers worldwide involved in the life
sciences, environmental, chemical and healthcare industries. With
projected ’07 sales exceeding $110 million
and 465 employees, Phenomenex spans the globe with offices in Canada,
the U.K., Germany, Austria, France, Italy, Denmark, Australia and New
Zealand.
For more information, visit www.phenomenex.com.
MULTIMEDIA GALLERY http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5359597
Trackback URL: http://www.prweb.com/pingpr.php/SGFsZi1Db3VwLVNxdWEtRmFsdS1NYWduLVplcm8=
|
